WENDER JOSEPH H

SEC Form 4 insider trading activity

WENDER JOSEPH H has filed 6 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Dec 3, 2025.

On the most recent filing, WENDER JOSEPH H is listed as Director at IONIS PHARMACEUTICALS INC. Inside the rolling window, WENDER JOSEPH H reported no open-market purchases and 3 open-market sales totaling $4.3M in IONS. The largest disclosed transaction in the window is a sale of 28,000 IONS shares on Dec 1, 2025, worth $2.3M.

Companies traded

Other insiders at IONS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
IONSSale$2.3MDec 3SEC ↗
IONSSale$1.2MNov 3SEC ↗
IONSSale$842KNov 3SEC ↗
Showing 1–3 of 3
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 1, 2025IONSSale$1.1M
Sep 3, 2025IONSSale$674K
Sep 2, 2025IONSSale$322K
Sep 2, 2025IONSSale$616K
Showing 1–4 of 4
1 / 1

Frequently asked questions

How many SEC Form 4 filings has WENDER JOSEPH H made?

WENDER JOSEPH H has filed 6 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.

Which companies does WENDER JOSEPH H trade?

WENDER JOSEPH H has filed SEC Form 4 disclosures for 1 company, including IONS.

When was WENDER JOSEPH H's most recent SEC Form 4 filing?

WENDER JOSEPH H's most recent SEC Form 4 filing on Tracefour is dated Dec 3, 2025.

What is WENDER JOSEPH H's total buy and sell value in the current window?

Inside the rolling retention window, WENDER JOSEPH H bought $0 and sold $4.3M based on SEC Form 4 filings.

What was WENDER JOSEPH H's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 28,000 IONS shares on 2025-12-01, worth $2.3M, per SEC Form 4 filings.